About Myriamed
Myriamed is a company based in Gottingen (Germany) founded in 2012. It operates as a B2B. The company has 12 employees as of December 31, 2021. Myriamed offers products and services including myrCell, myrTissue, myrPlate, myrImager, and myrScreen. Myriamed operates in a competitive market with competitors including Concateno, ICCR-Roßdorf, LeyshonBanks Toxicology, Mammoth Capital Ventures and Essem Compliance, among others.
- Headquarter Gottingen, Germany
- Employees 12 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Myriamed Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
12
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Myriamed
Myriamed offers a comprehensive portfolio of products and services, including myrCell, myrTissue, myrPlate, myrImager, and myrScreen.
Platform for simulating human cells in drug testing and discovery
Engineered tissues to mimic health and disease for research applications
Tools for advanced drug screening and phenotypic analysis
System for high-content analysis of stem cell-derived tissues
Enables deep phenotyping of drug effects on human tissues
Simulates diseases for testing therapeutic candidates
Funding Insights of Myriamed
Investments & Acquisitions by Myriamed
Financial Statements - Myriamed
Myriamed Comparisons
Competitors of Myriamed
Myriamed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Concateno, ICCR-Roßdorf, LeyshonBanks Toxicology, Mammoth Capital Ventures and Essem Compliance, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug research and development services are provided to biopharma firms.
|
|
| domain | founded_year | HQ Location |
Provider of reliable and high-quality toxicological services
|
|
| domain | founded_year | HQ Location |
Offers contract research services for toxicology studies.
|
|
| domain | founded_year | HQ Location |
Mammoth Capital Ventures is a CRO specializing in toxicology services for healthcare and pharmaceutical clients.
|
|
| domain | founded_year | HQ Location |
A clinical research organization providing GLP-compliant testing for pharmaceutical and chemical industries.
|
Latest news on Myriamed
Frequently Asked Questions about Myriamed
Myriamed was founded in 2012.
Myriamed is headquartered in Gottingen, Germany. It is registered at Gottingen, Niedersachsen, Germany.
As of Dec 31, 2021, the latest employee count at Myriamed is 12.
myriamed GmbH, based in Göttingen, Germany, focuses on accelerating drug development by offering proprietary human cell and engineered tissue models. These platforms simulate health and disease conditions, aiding pharmaceutical and biotech companies in early drug discovery and candidate refinement. By providing high-quality secondary screens, they help reduce attrition rates and enhance cost-effectiveness in developing new molecular entities for unmet medical needs.
Myriamed's top competitors include ICCR-Roßdorf, Concateno and LeyshonBanks Toxicology.
Myriamed offers myrCell, myrTissue, myrPlate, myrImager, and 2 more products and services.